Thermo Fisher, Cytonome/ST Announce Partnership
News Jun 28, 2016
Thermo Fisher Scientific has announced it has signed a strategic partnership agreement with Cytonome/ST to be the exclusive distributor of a new line of flow cytometry cell sorting technology that the companies will co-develop. The agreement combines Thermo Fisher’s extensive channel reach and commercialization capabilities and Cytonome’s sorting technology expertise and heritage of disruptive innovation.
“A key goal we are helping to fulfill through this strategic partnership is to enabling scientists work as efficiently and effectively as possible,” said Valerie Bressler-Hill, vice president and general manager of Flow Cytometry at Thermo Fisher. “We are extremely impressed with the quality and remarkable ease-of-use of Cytonome’s bench-top, cell-sorter platform.”
Systems that have very short learning curves and time-saving features are critical to expedite discovery, particularly for researchers who are not familiar with flow cytometry. A key objective of the partnership is to develop easy-to-use technology designed to initiate a transformation where any scientist can readily take advantage of cell sorting in their lab and use the power of these systems to garner insights faster than ever before.
“We are very enthusiastic about this new partnership,” said Cytonome CTO John Sharpe. “We look forward to collaborating with Thermo Fisher to introduce innovative platforms that will result from our partnership, which we believe will change the thinking around easy-to-use bench top cell sorting.”